Cardiovascular Market Research Reports & Industry Analysis

The Global Cardiovascular Drugs Market was valued at USD 153.7 billion in 2024 and is projected to grow at a CAGR of 3.5% to reach USD 214.9 billion by 2034. As the global burden of cardiovascular dis...

According to our (Global Info Research) latest study, the global Cardiovascular Equipment market size was valued at US$ 17420 million in 2024 and is forecast to a readjusted size of USD 20320 million...

... heart failure, Coronary artery disease, Ductus arteriosus, Fatigue, Hypercholesterolemia, Hypertension, Intermittent claudication, Ischemic heart disease, Limb ischemia, Marfan's Syndrome, Myocardial Infarction, Oedema (excess fluid), Palpitations, Peripheral arterial disease, Thrombus (blood clot), Valvular ...

... report analyzes the worldwide markets for Prosthetic Heart Valves in US$ by the following Segments: Tissue Heart Valves, Transcatheter Heart Valves, and Mechanical Heart Valves. The report provides separate ... are provided for the period 2015 through 2024. Market data and analytics are derived from primary and ...

... analyzes the worldwide markets for Cardiovascular Disease Monitoring and Diagnostic Devices in US$ Thousand by the following Segments: ECG Systems, Holter Monitors, Implantable Loop Recorders, and ...

This report analyzes the worldwide markets for Next Generation Sequencers in US$ Thousand. The Global market is additionally analyzed by the following End-Use Segments: Pharmaceutical/Biotech, Industrial, and Government/Academia. The report provides separate comprehensive analytics for the US, Canada, Japan, ...

This report analyzes the worldwide markets for Acute Myeloid Leukemia (AML) Therapeutics in US$ Thousand. The report ... 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...

This report analyzes the worldwide markets for Heart Healthy Ingredients in US$ by the following Product Segments: Omega-3 PUFA, Soy Protein, Phytosterols, ... 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...

... in the global cardiac holter monitor market. Market Segmentation: Global Cardiac holter monitor market is segmented on the basis of product Type, components, end users and regional outlook. 1. Global Cardiac holter monitor Market Research And Analysis, By product Type 2. Global Cardiac holter monitor Market ...

... three major categories: Cardiovascular Information System Market By Type Cardiovascular Information System Market By Applications Cardiovascular Information System Market By Deployment The report covers: Comprehensive research methodology of Global Cardiovascular Information System Market. This report also ...

... Inc., ZenoMed and so on. MARKET SEGMENTATION 1. GLOBAL CARDIAC ABLATION MARKET BY TECHNOLOGY 1.1. CRYOABLATION 1.2. ELECTRICAL ABLATION 1.3. MICROWAVE ABLATION 1.4. RADIOFREQUENCY ABLATION 1.5. ULTRASOUND ABLATION 2. GLOBAL CARDIAC ABLATION MARKET BY APPLICATION 2.1. CARDIAC RHYTHM MANAGEMENT 2.2. OPEN ...

... Global cardiology surgery, devices and drugs market is expected to grow at a CAGR of 7% for the forecasted period of 2015-2020. The report covers three major segments of cardiology surgery, devices ...

Cardiac rhythm management (CRM) is a well-established segment of the cardiology devices market. CRM majorly consists of devices such as implantable ... is expected. The report provides a comprehensive study of global cardiac rhythm management (CRM) market and also the regional markets. The competition in ...

... (ICD), implantable pacemakers, and other CRM monitoring devices. Cardiac rhythm management devices are commonly used for the ... market. The report, “Global Cardiac Rhythm Management Market: 2015 Edition” analyzes the fundamentals and development of global cardiac rhythm management market globally and in the US. ...

Competitor Analysis: Cardiovascular Peptides The present Competitive Intelligence Report about Cardiovascular Peptides used to treat or prevcent heart failure, myocardial infarction, thrombosis, hypertension, peripheral vascular diseases, hemostasis and wound sealing provides a competitor evaluation in the ...

... products, among the first in a new wave of medicines in late-stage development at Big Pharma for cardiovascular indications. Data from the PARADIGM-HF trial ... play a role in the company's price-setting calculus. Based on the new data, JP Morgan analyst Richard Vosser believes LCZ696 has 'multi-blockbuster ...

... Key questions focus on how enthusiastically the guidelines will be embraced by physicians and how rapidly. In a note to ... the PCSK9 inhibitors, a number of analysts have pointed out, however, that initial ... inhibitors. This week’s Physician Views poll will ask US-based cardiologists, general practioners and ...

... Ingelheim's Pradaxa was not a widely held view FirstWord Pharma PLUS subscribers can view the results and analysis from this poll ... . This week's FirstWord Physician Views poll will ask: How do the clinical profiles of oral anticoagulants compare with warfarin? How does the clinical profile ...

Cardiac rhythm management (CRM) is a well established segment of the cardiology devices market. CRM devices are commonly used for the treatment of arrhythmias and ...

This report analyzes the worldwide markets for Cholesterol & Other Cardiovascular Testing in Million Units by the following Product Segments: Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests ...

... obesity are the major factors which are driving the global heart valve market growth. Moreover, rising urban population which leads ... report provides an analysis of the global heart valve market. It also discusses the major trends, growth drivers and potential markets for heart valve market. The report ...

... babies are born with VSD in the United States. Most congenital heart diseases are diagnosed in babies (aged under a year), 30% in children (aged 1-15 ... current report analyzes the market size and segmentation of the congenital heart diseases market. The various drivers, opportunities and the challenges faced ...

... overall heart valve market and provide higher risk patients with a less invasive approach. The penetration of worldwide risk/ ... valve segment. The report provides an analysis of the global heart valve market. It also discusses major trends, growth drivers and potential markets for heart valve market. The report ...

This report analyzes the worldwide markets for Interventional Cardiology in US$ Million. The market for Interventional Cardiology Devices is analyzed by the following product segments: Coronary Stents, Peripheral Devices, Angioplasty Catheters, Intravascular Ultrasound, Vascular Sealings/ Vascular Closure ...

... indication established by the FDA, would also open new growth avenues for LVADs. The report provides an overview of the heart failure and ... the associated end stage heart failure cost and LVAD reimbursement. The growth drivers and challenges are also discussed. The key ...

... worldwide annually. In the US alone, around five million people suffer from heart problems. In heart valve market, mechanical valves are more durable than tissue heart valves ... of the heart valve market. It analyzes the worldwide and US market. Apart from providing a competitive landscape of the market, the ...

... devices - Cardiac Rhythm Management (CRM), which mainly comprises Implantable Cardiac Rhythm Devices (ICD) and Pacemakers. ICDs constitute more than 60% of the global CRM market and served ...

Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request. This report will be delivered in 7-10 workin...

Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request. This report will be delivered in 7-10 workin...

Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request. This report will be delivered in 7-10 workin...

Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request. This report will be delivered in 7-10 workin...

The global kawasaki disease market is poised for steady expansion over the forecast period, driven by increasing disease incidence, improved clinical recognition, and advancements in pediatric care in...

The global pulmonary embolism market is expected to experience steady growth, driven by the increasing prevalence of deep vein thrombosis (DVT) and pulmonary embolism (PE) among aging populations and...

The global von willebrand disease market is witnessing steady growth driven by rising awareness of rare bleeding disorders, improved diagnostic capabilities, and growing adoption of recombinant and pl...

The venous thromboembolism (VTE) market spans therapeutics (primarily oral anticoagulants such as DOACs, plus LMWHs and heparins), interventional devices (catheter-directed thrombolysis, mechanical th...

Heterozygous familial hypercholesterolemia (HeFH) is a genetic disorder that results in elevated cholesterol levels, leading to an increased risk of early cardiovascular diseases. It is caused by a mu...

The global arteriovenous fistula market is witnessing steady growth, driven by the increasing prevalence of chronic kidney disease (CKD), the rising number of hemodialysis procedures, and advancements...

The global arteriovenous malformations market is witnessing robust growth driven by the increasing incidence of congenital and acquired vascular abnormalities, advancements in neurovascular imaging, a...

The global paroxysmal supraventricular tachycardia (PSVT) market is experiencing significant growth, driven by advancements in diagnostic technologies, treatment options, and increasing awareness of c...